Cyclodextrin Electrochemical Sensor for Phenazine Metabolite Resolution

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing electrochemical sensors for detecting pathogenic metabolites, such as those produced by bacteria like Pseudomonas aeruginosa, suffer from limited specificity and sensitivity, particularly in differentiating between various phenazine metabolites.

Innovation Solution

An electrochemical sensor modified with oligosaccharide molecules, specifically cyclodextrins, is used to enhance specificity and sensitivity by forming complexes with target metabolites, coupled with techniques like square wave adsorptive stripping voltammetry (SWASV) for detection.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If unmodified electrodes or conventional detection methods are used, then the device complexity is low, but the measurement precision and specificity for differentiating phenazine metabolites are limited

Engineering Contradiction:
ImprovespecificityVSAvoidelectrode modification complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

Cyclodextrin molecules are used as intermediary substances that form inclusion complexes with phenazine metabolites. These cyclodextrins are immobilized on the electrode surface, acting as mediators that selectively bind to target metabolites and enhance their electrochemical detection signals, thereby improving measurement precision without requiring complex device architecture

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The electrode is modified with composite materials consisting of cyclodextrin molecules combined with conductive polymers or nanomaterials. This composite structure provides both the selective recognition capability of cyclodextrins and the enhanced electrochemical properties of the supporting materials, achieving high specificity while maintaining reasonable device complexity

Inventive Principle:
Principle #40Composite materials

2Measurement precision

If conventional electrochemical detection methods are used, then the device complexity is low, but the measurement precision for detecting low concentrations of metabolites is insufficient

Engineering Contradiction:
Improvedetection sensitivityVSAvoiddetection method complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The cyclodextrin molecules are pre-immobilized on the electrode surface before sample introduction. This preliminary action creates a ready-to-use selective recognition layer that can immediately capture and concentrate target metabolites upon sample contact, enhancing detection sensitivity without requiring complex real-time processing

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The detection method employs square wave adsorptive stripping voltammetry (SWASV) which utilizes controlled potential changes and time-dependent adsorption processes. By optimizing parameters such as accumulation time, potential amplitude, and scan rate, the method achieves enhanced sensitivity for trace metabolite detection while maintaining a relatively simple electrochemical cell configuration

Inventive Principle:
Principle #35Parameter changes

3Measurement precision

If unmodified electrodes are used, then the ease of manufacture is high, but the measurement precision for resolving multiple phenazine signals is poor

Engineering Contradiction:
Improvesignal resolutionVSAvoidelectrode fabrication ease
Core Design Contradiction:
Measurement precisionVSEase of manufacture

Solution Approach 1:

Cyclodextrin molecules serve as intermediary recognition elements that are chemically or physically attached to the electrode surface. These intermediaries provide selective binding sites for different phenazine metabolites, enabling signal resolution through differential complex formation constants, while the overall fabrication process remains relatively straightforward

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The electrode surface is modified with cyclodextrin molecules that create localized recognition sites with specific binding properties. Different regions of the electrode surface maintain the base electrode properties while the cyclodextrin-modified regions provide selective recognition, achieving signal resolution without requiring complete redesign of the entire electrode structure

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The sensor provides improved resolution of redox peaks, enabling accurate identification and quantification of multiple phenazine metabolites, facilitating early detection of bacterial quorum sensing and species differentiation.

Implementation Method 1

The modified electrode is used for detecting pathogenic metabolites. The modification with oligosaccharide molecules, specifically cyclodextrins, enhances specificity and sensitivity by forming complexes with target metabolites

Methodology Applied
Scientific EffectInclusion complex formation: Solvation

Implementation Method 2

Electrochemical sensing may be used as relatively simple technique for pathogen identification via the detection of redox-active metabolites on an electrode surface

Methodology Applied
Scientific EffectRedox reactions: Redox Reactions

Data Source

PatentUS20250341489A1An electrochemical sensor and method for detecting pathogenic metabolites
Publication Date: 2025.11.06 UNIVERSITY OF DURHAM
  • US20250341489A1 patent drawing
  • US20250341489A1 patent drawing
  • US20250341489A1 patent drawing

AI summary

An electrochemical sensor and a method for detecting pathogenic metabolites such as viral or bacterial metabolites are presented. The electrochemical sensor includes a first electrode modified with oligosaccharide molecules. In the detection method, a first electrode modified with oligosaccharide molecules is provided and a sample is applied on the first electrode. An electrochemical response is then measured using the first electrode to detect pathogenic metabolites in the sample.